News

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause transthyretin…

HistoryThe subtype of TTR protein mutation, its tissue distribution, and the amount of amyloid deposition largely determine the clinical manifestations of ATTR. The…

An amyloidosis diagnosis brings a rush of questions. Where should I go? Who truly understands this disease? Are there clinical trials for someone like me? For too…

Each year, landmarks, homes, and communities across the country light up in red to honor those affected by amyloidosis and to raise awareness of this rare disease.…

AbstractThe growing pressures of population expansion, resource depletion, and climate change are intensifying global challenges in health, food security, and…

Each year, landmarks, homes, and communities across the country light up in red to honor those affected by amyloidosis and to raise awareness of this rare disease.…

AbstractBackgroundAcquired transthyretin (ATTR) amyloidosis is increasingly reported among domino liver transplantation (DLT) recipients who receive livers from…

Accurate differentiation between light-chain (AL) amyloidosis and transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is critical for effective patient…

Northfield, Ill. (November 24, 2025) — A new evidence-based guideline to help standardize the diagnosis of amyloidosis and improve patient care, was just published…

Key TakeawaysATTR-CM is a rare heart failure type caused by transthyretin protein buildup, leading to heart muscle thickening and symptoms such as shortness of…